Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids)
Patents for A61P 29 - Non-central analgesic, antipyretic or antiinflammatory agents, e.g antirheumatic agents; Non-steroidal antiinflammatory drugs (nsaids) (127,169)
06/2012
06/07/2012US20120142664 Novel benzyl azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142663 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142662 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142661 Novel oxime azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142658 Therapeutical use of ternary complexes of valproic acid
06/07/2012US20120142651 Method of treatment of allergic rhinitis
06/07/2012US20120142649 Compositions and methods for delivering clonidine and bupivacaine to a target tissue site
06/07/2012US20120142648 Methods for delivering clonidine compositions in biodegradable polymer carrier and local steriods to a target tissue site
06/07/2012US20120142646 Novel Compounds 621
06/07/2012US20120142643 Clonidine and gaba compounds in a biodegradable polymer carrier
06/07/2012US20120142642 Novel oxime derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142640 Alkyne and alkene derivatives as sphingosine 1-phosphate-1 receptor modulators
06/07/2012US20120142639 Oxadiazole derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012US20120142638 Combination of organic compounds
06/07/2012US20120142637 Prodrugs of 6-cyclohexyl-1-hydroxy-4-methylpyridin-2-(1h)- one and derivatives thereof
06/07/2012US20120142629 Pharmaceutical composition for relieving pain
06/07/2012US20120142620 Core 2 glcnac-t inhibitors
06/07/2012US20120142619 Medicinal carbohydrates for treatment of respiratory conditions
06/07/2012US20120142615 Methods related to the treatment of neurodegenerative and inflammatory conditions
06/07/2012US20120142614 Guanylate Cyclase Receptor Agonists For The Treatment Of Tissue Inflammation And Carcinogenesis
06/07/2012US20120142610 Treatment of 'iq motif containing gtpase activating protein' (iqgap) related diseases by inhibition of natural antisense transcript to iqgap
06/07/2012US20120142601 Modified Peptides and Uses Thereof
06/07/2012US20120142589 Tissue-protective cytokines for the protection, restoration and enhancement of responsive cells, tissues and organs
06/07/2012US20120142585 Leptin antagonist and methods of use
06/07/2012US20120142584 Novel transporter constructs and transporter cargo conjugate molecules
06/07/2012US20120141617 Compositions comprising docynia delavajy extract and/or elaeagnus lancelotus extract
06/07/2012US20120141611 Methods and compositions using ergothioneine to treat a variety of health related factors
06/07/2012US20120141595 Umbilical cord amniotic membrane products
06/07/2012US20120141594 Composition with anti-inflammatory, protein synthesizing, enzyme deficiency activating genetic therapy, and anti-cancer activity and methods of use
06/07/2012US20120141588 Dentifrice compositions containing calcium silicate and a basic amino acid
06/07/2012US20120141587 Compositions and methods for treatment or prevention of post-operative organ or tissue inflammation
06/07/2012US20120141584 Multilayer Minitablets
06/07/2012US20120141583 Alcohol resistant dosage forms
06/07/2012US20120141575 Collagen For Use In The Treatment Of Skin Diseases
06/07/2012US20120141574 Process for Manufacturing Chewable Dosage Forms for Drug Delivery and Products Thereof
06/07/2012US20120141573 Cell Lines That Secrete Anti-Angiogenic Antibody-Scaffolds and Soluble Receptors and Uses Thereof
06/07/2012US20120141565 Glycerosomes and use thereof in pharmaceutical and cosmetic preparations for topical applications
06/07/2012US20120141564 Compositions and methods of treating inflammation
06/07/2012US20120141562 Cell coated implantable device
06/07/2012US20120141558 Alginate-based nanofibers and related scaffolds
06/07/2012US20120141549 Oligonucleotides targeting asthma inflammation processes
06/07/2012US20120141545 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141544 Solid Dosage Form That Promotes Reliable Oral, Esophageal and GI Transit
06/07/2012US20120141541 Synergistic mixture of beta-galacto-oligosaccharides with beta-1,3 and beta-1,4/1,6 linkages
06/07/2012US20120141538 Modulators of the cx3cri receptor and therapeutic uses thereof
06/07/2012US20120141532 Botulinum Toxin Formulation
06/07/2012US20120141514 Use of a chemically-stabilized chlorite solution for inhibiting an antigen-specific immune response
06/07/2012US20120141504 Methods for treating inflammation using b7-h4 polypeptides and fragments thereof
06/07/2012US20120141492 Anti-il 17a /il-17f cross-reactive antibodies and methods of use thereof
06/07/2012US20120141486 Human monoclonal antibody
06/07/2012US20120141464 Binding member for gm-csf receptor
06/07/2012US20120141458 Compositions and methods for treatment in broad-spectrum, undifferentiated or mixed clinical applications
06/07/2012US20120141457 Lateral Flow Immunoassay for Complement Activation and Methods of Use for Point-of-Care Assessment of Complement-Associated Disorders
06/07/2012US20120141455 Insoluble dietary fiber-containing materials derived from cereal seeds
06/07/2012US20120141449 Albumin Fusion Proteins
06/07/2012US20120141444 Nutritionally balanced standard tube feeding formula containing probiotics
06/07/2012US20120141443 Short-time high temperature treatment generates microbial preparations with anti-inflammatory profiles
06/07/2012US20120141428 Muscle-derived cells (mdcs) for treating muscle- or bone-related injury or dysfunction
06/07/2012US20120141416 Multimeric peptide conjugates and uses thereof
06/07/2012US20120141415 Albumin Fusion Proteins
06/07/2012US20120141411 Uses of IL-174 Antagonists for Inhibiting A Th2 Immune Response
06/07/2012US20120141401 Soft anticholinergic zwitterions
06/07/2012US20120141392 Methods of modulating the activity of the mc1 receptor and treatment of conditions related to this receptor
06/07/2012US20120141380 Polymer nanoparticles coated by magnetic metal oxide and uses thereof
06/07/2012US20120141379 Microspheres for active embolization
06/07/2012CA2819648A1 Substituted purine and 7-deazapurine compounds
06/07/2012CA2819619A1 Novel azetidine derivatives as sphingosine 1-phosphate (s1p) receptor modulators
06/07/2012CA2819460A1 Orally disintegrating tablet
06/07/2012CA2819457A1 Pharmaceutical compositions comprising 3,4-dihydroisoquinolin-2(1h)-yl-3-phenylurea derivatives having formyl peptide receptor like-1 (fprl-1) agonist or antagonist activity
06/07/2012CA2819442A1 Use of sigma ligands in bone cancer pain
06/07/2012CA2818495A1 Methods for the treatment of fibromyalgia and chronic fatigue syndrome
06/06/2012EP2460805A1 Fused imidazole derivative having ttk inhibitory action
06/06/2012EP2460794A1 Pharmaceutical composition containing fused hetero-ring derivative
06/06/2012EP2460793A1 Substituted Benzofurans, Benzothiophenes, Benzoselenophenes and Indoles And Their Use as Tubulin Polymerisation Inhibitors
06/06/2012EP2460524A1 Medicinal composition for iontophoresis
06/06/2012EP2460519A1 Use of sigma ligands in bone cancer pain
06/06/2012EP2459572A2 Spirocyclic amide derivatives
06/06/2012EP2459566A1 Tricyclic inhibitors of jak
06/06/2012EP2459565A2 Methods and compositions for studying, imaging, and treating pain
06/06/2012EP2459559A1 Condensed pyridine derivatives useful as potent inhibitors of the protein kinase ck2
06/06/2012EP2459556A1 2, 7 -naphthyridin- 1 -one derivatives as syk kinase inhibitors
06/06/2012EP2459543A1 Benzo [e][1, 3]oxazin-4-one derivatives as phosphoinositide 3-kinase inhibitors
06/06/2012EP2459535A1 Pyridine and pyrazine derivatives as protein kinase modulators
06/06/2012EP2459530A1 2-amino-2-phenyl-alkanol derivatives, preparation thereof, and pharmaceutical compositions containing same
06/06/2012EP2459524A2 Novel compounds as modulators of glucocorticoid receptors
06/06/2012EP2459510A1 Hydroxy fatty acid compounds and uses thereof for disease treatment and diagnosis
06/06/2012EP2459203A1 Lactic acid bacteria and bifidobacteria for treating endotoxemia
06/06/2012EP2459192A1 Methods of treating neuropathic pain with benzimidazole derivative agonists of ppargamma
06/06/2012EP2459189A1 Fatty acids as anti-inflammatory agents
06/06/2012EP2459182A1 Injectable formulation for treatment and protection of patients having an inflammatory reaction or an ischemia-reperfusion event
06/06/2012EP2458988A1 Treating critically ill patients with intravenous ibuprofen
06/06/2012EP2334674B1 Pyridazino- pyridinone compounds for the treatment of protein kinase mediated diseases.
06/06/2012EP2205599B1 Cgrp antagonists
06/06/2012EP2114423B1 Product containing inactivated probiotic for infants
06/06/2012EP2004693B1 Compositions and methods of use for antibodies of c-met
06/06/2012EP1620108B1 Pyrazole-amine compounds useful as kinase inhibitors
06/06/2012EP1616575B1 Method for treating inflammation
06/06/2012CN202263198U Complex gastrointestinal capsule containing combination of diclofenac sodium and acetaminophen
06/06/2012CN202263197U Double-layered packaged compound naproxen capsule
06/06/2012CN102485741A Methyl reduced oleanane triterpenoid, its preparation method and application
1 ... 181 182 183 184 185 186 187 188 189 190 191 192 193 194 195 196 197 198 199 200 201 ... 1272